文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症患者插管时预氧合与无呼吸氧合效果的网状Meta分析

[Effect of preoxygenation and apnoeic oxygenation during intubation in the critically ill patients: a network Meta-analysis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论网状Meta分析提示,重症患者插管时采用经鼻高流量氧疗联合无创通气预氧合、并经鼻高流量氧疗无呼吸氧合,可能是优先选择。

该网状Meta分析系统检索PubMed、Embase、Cochrane图书馆、CNKI及万方数据库至2019年1月30日,纳入7项随机对照试验共796例重症监护病房患者,比较预氧合联合无呼吸氧合与单独预氧合的效果。网状Meta分析显示,与无压力面罩预氧合相比,经鼻高流量氧疗联合无创通气预氧合加经鼻高流量氧疗无呼吸氧合(OR=51.20,95%CI 2.06~3518.68)及无创通气预氧合(OR=5.80,95%CI 1.25~34.70)显著降低血氧饱和度低于0.80的发生率(均P<0.05);各技术间严重并发症发生率无显著差异。作者结论认为,经鼻高流量氧疗联合无创通气预氧合加经鼻高流量氧疗无呼吸氧合应为重症患者插管的优先选择。

要点

  • 预氧合联合无呼吸氧合较单独预氧合显著降低插管严重并发症发生率(OR=0.54,95%CI 0.32~0.92,P=0.02)。
  • 预氧合联合无呼吸氧合对血氧饱和度低于0.80的发生率未见显著改善(OR=0.65,95%CI 0.40~1.05,P=0.08)。
  • 网状Meta分析显示,与无压力面罩预氧合相比,经鼻高流量氧疗联合无创通气预氧合加经鼻高流量氧疗无呼吸氧合显著降低血氧饱和度低于0.80的发生率(OR=51.20,95%CI 2.06~3518.68)。
  • 与无压力面罩预氧合相比,无创通气预氧合显著降低血氧饱和度低于0.80的发生率(OR=5.80,95%CI 1.25~34.70);各技术间严重并发症发生率无显著差异。

适用人群与场景

  • 重症监护病房中需要气管插管的危重患者,纳入7项随机对照试验共796例。

诊断标准与关键阈值

  • 插管过程中严重血氧饱和度下降定义为脉搏血氧饱和度<0.80。
  • 插管相关严重并发症包括脉搏血氧饱和度<0.80、收缩压<80 mmHg(1 mmHg=0.133 kPa)、血管活性药物剂量增加30%、心脏骤停和死亡。

处置流程与药物剂量

  • 预氧合技术包括鼻导管、经鼻高流量氧疗、球囊面罩、双水平正压通气、非重复呼吸面罩和无创通气等;无呼吸氧合技术指经鼻高流量氧疗。
  • 试验组策略为预氧合联合无呼吸氧合,对照组策略为单独预氧合。
  • 网状Meta分析中,经鼻高流量氧疗联合无创通气预氧合加经鼻高流量氧疗无呼吸氧合、经鼻高流量氧疗预氧合加经鼻高流量氧疗无呼吸氧合、无创通气预氧合及无压力面罩预氧合下,血氧饱和度低于0.80和严重并发症发生率依次降低。
  • 作者结论认为,经鼻高流量氧疗联合无创通气预氧合加经鼻高流量氧疗无呼吸氧合应为重症患者插管的优先选择。

研究设计与关键结果

  • 研究类型为网状Meta分析,纳入7项随机对照试验共796例重症监护病房患者,比较预氧合联合无呼吸氧合(试验组)与单独预氧合(对照组)。
  • 与对照组相比,试验组插管严重并发症发生率显著降低(OR=0.54,95%CI 0.32~0.92,P=0.02)。
  • 与对照组相比,试验组血氧饱和度低于0.80的发生率未见显著改善(OR=0.65,95%CI 0.40~1.05,P=0.08)。
  • 网状Meta分析显示,与无压力面罩预氧合相比,经鼻高流量氧疗联合无创通气预氧合加经鼻高流量氧疗无呼吸氧合(OR=51.20,95%CI 2.06~3518.68)和无创通气预氧合(OR=5.80,95%CI 1.25~34.70)显著降低血氧饱和度低于0.80的发生率(均P<0.05)。
  • 经鼻高流量氧疗联合无创通气预氧合加经鼻高流量氧疗无呼吸氧合、经鼻高流量氧疗预氧合加经鼻高流量氧疗无呼吸氧合、无创通气预氧合及无压力面罩预氧合之间,插管严重并发症发生率无显著差异。

证据类型、等级与局限

  • 证据类型为网状Meta分析,纳入7项随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,经鼻高流量氧疗联合无创通气预氧合加经鼻高流量氧疗无呼吸氧合应为重症患者插管的优先选择。
  • 网状Meta分析中,经鼻高流量氧疗联合无创通气预氧合加经鼻高流量氧疗无呼吸氧合和无创通气预氧合较无压力面罩预氧合显著降低插管过程中血氧饱和度低于0.80的发生率;各技术间严重并发症发生率无显著差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
  • 另有 3 条提炼内容因数值无法与原文逐一核对而未列出,请以原文为准。
英文原文(摘要)· 点击展开

OBJECTIVE: To systematic review the effect of preoxygenation (PreOx) and apnoeic oxygenation (ApOx) during intubation in the critically ill patients by network Meta-analysis.

METHODS: The PubMed, Embase, the Cochrane Library, CNKI and Wanfang Data were searched by computer to collect randomized controlled trials (RCT) of PreOx and ApOx techniques in the intensive care unit (ICU) from inception to January 30th, 2019. PreOx techniques (p) included nasal cannula (NC), high flow nasal cannula (HFNC), bag valve mask (BVM), bi-level positive airway pressure (BiPAP), non-rebreather mask (NRM) and non-invasive ventilation (NIV), etc.; ApOx technique (a) referred to HFNC. Experimental group strategy was PreOx combined with ApOx, and control group strategy was PreOx alone. The outcomes were as follows: the lowest value of pulse oximetry (SpO2) during the intubation procedure, the incidence of severe desaturations (SpO2< 0.80), and severe intubation-related complications [including SpO2< 0.80, systolic blood pressure < 80 mmHg (1 mmHg = 0.133 kPa), vasopressor 30% dose increment, cardiac arrest and death]. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Statistic analysis was performed by RevMan 5.3 software, Stata 15.1 software and WinBUGS 1.4.3 software.

RESULTS: A total of 7 RCTs involving 796 patients were included. Meta-analysis showed that, compared with the control group, the lowest SpO2 in the experimental group was significantly increased [mean difference (MD) = 1.42, 95% confidence interval (95%CI) was 0.60 to 2.25, P = 0.000 7], the incidence of severe complications was significantly decreased [odds ratio (OR) = 0.54, 95%CI was 0.32 to 0.92, P = 0.02], but the incidence of SpO2 < 0.80 did not improve significantly (OR = 0.65, 95%CI was 0.40 to 1.05, P = 0.08). The network Meta-analysis showed that, compared with non-pressure mask (NPM)p, (HFNC+NIV)p+HFNCa (OR = 51.20, 95%CI was 2.06 to 3 518.68) and NIVp (OR = 5.80, 95%CI was 1.25 to 34.70) had a significant reduction in the incidence of SpO2 < 0.80 (both P < 0.05). There were no significant differences in the incidence of severe complications during intubation among (HFNC+NIV)p+HFNCa, HFNCp+HFNCa, NIVp and NPMp. The occurrence rate of SpO2 < 0.80 and severe complications using different oxygenation techniques decreased sequentially in NPMp, HFNCp+HFNCa, NIVp and (HFNC+NIV)p+HFNCa.

CONCLUSIONS: (HFNC+NIV)p+HFNCa should be of a priority choice for critically ill patients during intubation.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Cao L, Zheng H, Xie Y, et al. [Effect of preoxygenation and apnoeic oxygenation during intubation in the critically ill patients: a network Meta-analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31771721. doi:10.3760/cma.j.issn.2095-4352.2019.10.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。